Indefinite Delivery Contract SPE2DB24D2011

The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The IDC has a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The contract serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Firm fixed price task orders issued under this IDC have enabled the provision of a comprehensive range of medications and healthcare materials, including specialty, brand name, generic, and over-the-counter pharmaceuticals, as well as medical materials such as syringes, vials, test kits, and other critical care supplies. The IDC does not fall under any overarching contract vehicles and was awarded solely to Amerisourcebergen Drug Corp as a single award contract. In addition to the DLA IDC, Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.